119 related articles for article (PubMed ID: 4665529)
1. [Regulation of cholesterol synthesis in the rat liver under the influence of serum cholesterol-decreasing drugs].
Kaiser W; Zöllner N
Verh Dtsch Ges Inn Med; 1972; 78():1307-10. PubMed ID: 4665529
[No Abstract] [Full Text] [Related]
2. Regulation of hepatic cholesterol biosynthesis by clofibrate administration.
White LW
J Pharmacol Exp Ther; 1971 Aug; 178(2):361-70. PubMed ID: 5570460
[No Abstract] [Full Text] [Related]
3. [Action of etofibrate, clofibrate and nicotinic acid on the metabolism of lipids in normolipemic rats. Short term effects and method of action].
Priego JG; Piña M; Armijo M; Sunkel C; Maroto ML
Arch Farmacol Toxicol; 1979 Apr; 5(1):29-42. PubMed ID: 38756
[No Abstract] [Full Text] [Related]
4. [Enzyme-inducing activities of hypolipidemic agents and ultrastructural changes of the liver elicited by clofibrate (author's transl)].
Araki Y; Amagase H
Fukuoka Igaku Zasshi; 1974 Jul; 65(7):465-72. PubMed ID: 4474120
[No Abstract] [Full Text] [Related]
5. Comparison of clofibrate and ethyl-5-(p-chlorophenoxy)-3-hydroxy-3-methylpentanoate induced changes in serum lipoprotein cholesterol and hepatic peroxisome proliferation in the normal rat.
Stevens TJ; Stafford WW; Day CE; Block EM
Artery; 1983; 12(2):81-94. PubMed ID: 6678582
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology of hypolipidemic drugs. Introduction.
Azarnoff DL
Fed Proc; 1971; 30(3):827-8. PubMed ID: 5575294
[No Abstract] [Full Text] [Related]
7. Newer hypolipidemic agents.
Kritchevsky D
Fed Proc; 1971; 30(3):835-40. PubMed ID: 4996475
[No Abstract] [Full Text] [Related]
8. Lipid lowering influence of ethyl p-chlorophenoxyisobutyrate in liver of rats fed high fat diets.
Kokatnur MG; Malcom GT
Metabolism; 1970 Feb; 19(2):120-8. PubMed ID: 5410942
[No Abstract] [Full Text] [Related]
9. Effect of policosanol on the hepatic cholesterol biosynthesis of normocholesterolemic rats.
Menendez R; Amor AM; Gonzalez RM; Fraga V; Mas R
Biol Res; 1996; 29(2):253-7. PubMed ID: 9278716
[TBL] [Abstract][Full Text] [Related]
10. Effects of etofibrate, clofibrate and nicotinic acid on lipid metabolism in normolipemic rats.
Priego JG; Maroto ML; Piña M; Catalan RE
Gen Pharmacol; 1979; 10(3):215-9. PubMed ID: 467961
[No Abstract] [Full Text] [Related]
11. Study of an inhibitor of hepatic cholesterol synthesis found in kidney microsomes.
Le-Phuc-Thuy ; Haven GT; Jacobi HP; Ruegamer WR
Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):135-48. PubMed ID: 4686097
[No Abstract] [Full Text] [Related]
12. [Screening of drugs inhibiting cholesterol synthesis].
Bibikova MB
Antibiot Khimioter; 1997; 42(8):21-5. PubMed ID: 9412407
[TBL] [Abstract][Full Text] [Related]
13. [The effect of orotic and nicotinic acids on the incorporation of 1-C14-acetate into the total lipids and cholesterol of rat liver].
Chagovets RV; Shushevich SI; Khalmuradov AG
Vopr Pitan; 1966; 25(2):24-9. PubMed ID: 5998316
[No Abstract] [Full Text] [Related]
14. Species differences in the inhibiting effect of fluvastatin, a new inhibitor of HMG-CoA reductase, on cholesterol biosynthesis.
Yamamoto A; Itoh S; Hoshi K; Ichihara K
Res Commun Mol Pathol Pharmacol; 1994 Dec; 86(3):325-34. PubMed ID: 7712108
[TBL] [Abstract][Full Text] [Related]
15. Hypolipidemic activity of some derivatives of 6H-dibenzo[b,d]pyran.
Banzatti C; Branzoli U; Lovisolo PP; Melloni P; Orsini G; Salvadori P
Arzneimittelforschung; 1984; 34(8):864-9. PubMed ID: 6541922
[TBL] [Abstract][Full Text] [Related]
16. Aminophenyl ether compound (YM-95831), a new hypolipidemic agent with a high density lipoprotein elevating activity in rats.
Ohata I; Sakamoto N; Nitatori R; Maeno H
Arzneimittelforschung; 1983; 33(2):237-41. PubMed ID: 6682662
[TBL] [Abstract][Full Text] [Related]
17. Anticholesterolemic effect of 3,4-di(OH)-phenylpropionic amides in high-cholesterol fed rats.
Kim SJ; Bok SH; Lee S; Kim HJ; Lee MK; Park YB; Choi MS
Toxicol Appl Pharmacol; 2005 Oct; 208(1):29-36. PubMed ID: 16164959
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of N-N-bis-P-chlorophenyl-3p-tolyl glutaric acid diamide (SRC-3605) as a hypocholesterolaemic compound in hypercholesterolaemic female weanling and adult rats.
Gujral S; Puar M; Ranka N
Indian J Physiol Pharmacol; 1978; 22(3):279-84. PubMed ID: 721249
[TBL] [Abstract][Full Text] [Related]
19. Effect of SaH 42-348, an analog of clofibrate, on lipid metabolism in rats.
Kritchevsky D; Tepper SA
Arzneimittelforschung; 1973 Jun; 23(6):858-9. PubMed ID: 4740771
[No Abstract] [Full Text] [Related]
20. The application of a simple method to determine the mode of action of oral antihypercholesteremic drugs.
Brandau K; Schlossmann K
Arzneimittelforschung; 1974 Oct; 24(10):1535-42. PubMed ID: 4479759
[No Abstract] [Full Text] [Related]
[Next] [New Search]
